Kriya Therapeutics is a leading biopharmaceutical company dedicated to developing revolutionary gene therapies that have the potential to transform the lives of millions of individuals worldwide. With their headquarters in Palo Alto, California and research and manufacturing teams located in Research Triangle Park, North Carolina, Kriya has secured over $600 million in funding to advance their extensive pipeline of gene therapies targeting ophthalmology, neurology, and metabolic diseases. At Kriya Therapeutics, their cultural values are at the heart of everything they do.

They foster a collaborative environment where ideas are freely shared and challenged, encouraging respectful debates to drive innovation. They approach problems with curiosity and open-mindedness, constantly disrupting conventional norms to push boundaries. Kriya is committed to protecting their intellectual property and continually evolving their processes and efficiencies to stay at the forefront of the industry.

Trust Kriya Therapeutics to lead the way in developing groundbreaking gene therapies that make a real difference in the lives of patients